Home › Funds › Timothy G. Youngquist 2020 Irrevocable Trust › VKTX
Timothy G. Youngquist 2020 Irrevocable Trust position in VKTX
VIKING THERAPEUTICS INC · Health Care
Timothy G. Youngquist 2020 Irrevocable Trust reported holding 271,849 shares of VKTX (VIKING THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.9M, representing 1.81% of its reported portfolio and ranking #9 among its reported holdings. Timothy G. Youngquist 2020 Irrevocable Trust has disclosed VKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Timothy G. Youngquist 2020 Irrevocable Trust's VKTX position evolved
Timothy G. Youngquist 2020 Irrevocable Trust first disclosed a stake in VKTX in Q4 2025 at 112,500 shares (US$4.0M). The position peaked in Q2 2026 at 271,849 shares, worth US$10.6M. Across 4 filings, Timothy G. Youngquist 2020 Irrevocable Trust increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 271,849 shares valued at US$8.9M. Notable position changes include a 142% increase in Q2 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 112.50K | $3.96M | New |
| Q1 2026 | 112.50K | $3.66M | Hold |
| Q2 2026 | 271.85K | $10.60M | Add |
| Q3 2026 | 271.85K | $8.86M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on Timothy G. Youngquist 2020 Irrevocable Trust
FAQ
How long has Timothy G. Youngquist 2020 Irrevocable Trust held VKTX?
Timothy G. Youngquist 2020 Irrevocable Trust has disclosed VKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Timothy G. Youngquist 2020 Irrevocable Trust's current position in VKTX?
As of Q3 2026, Timothy G. Youngquist 2020 Irrevocable Trust holds 271.85K shares of VKTX (VIKING THERAPEUTICS INC), valued at $8.86M, representing 1.81% of its reported portfolio and ranking #9.
Has Timothy G. Youngquist 2020 Irrevocable Trust been buying or selling VKTX?
In the latest 13F filing (Q3 2026), Timothy G. Youngquist 2020 Irrevocable Trust held unchanged its position in VKTX. The position peaked in Q2 2026 at 271.85K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.